[PDF][PDF] 奥希替尼用于EGFR+ 晚期非小细胞肺癌患者一线治疗的药物经济学评价
刘心怡， 陈文 - 世界临床药物, 2021 - jwph.com.cn
… The efficacy data of these therapies was retrieved from the FLAURA trial, and the cost was
collected from … Results Compared with erlotinib, gefitinib, afatinib and icotinib, osimertinib with …
collected from … Results Compared with erlotinib, gefitinib, afatinib and icotinib, osimertinib with …
非小细胞肺癌脑转移治疗进展
崔永奇， 郑宇， 张丽妍， 谭晓明 - 中华肺部疾病杂志(电子 …, 2019 - zhfbjbzz.cma-cmc.com.cn
… Effects of acetylcysteine tablets combined with methylprednisolone on blood gas indexes,
pulmonary function and serum inflammatory factors of IIP patients[J]. Chinese Journal of Lung …
pulmonary function and serum inflammatory factors of IIP patients[J]. Chinese Journal of Lung …
[PDF][PDF] 非小细胞肺癌患者EGFR‑TKI 相关间质性肺疾病发生情况的meta 分析
李姗姗， 徐晓涵， 吴紫阳， 翟所迪， 温剑， 程吟楚 - 药物不良反应杂志, 2022 - cadrj.com
… , including 6 about gefitinib, 5 about erlotinib, 2 about icotinib, … no significant difference in
ILD occurrence between the trial … The efficacy and safety of icotinib in patients with advanced …
ILD occurrence between the trial … The efficacy and safety of icotinib in patients with advanced …
[PDF][PDF] 厄洛替尼治疗晚期非小细胞肺癌92 例临床观察
顾爱琴， 熊丽纹， 王慧敏， 施春雷， 高志强， 韩宝惠 - 2009 - core.ac.uk
… was to evaluate the efficacy and safety of erlotinib for the … rate of erlotinib did not show
significant differences within … with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci …
significant differences within … with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci …
EGFR 靶向治疗的现状机遇和挑战
高琳， 虞永峰， 陆舜 - 中国肿瘤临床, 2021 - cjco.cn
… 最常见的不良反应(adverse events,AEs)是皮 肤和胃肠道反应.第二代药物的AEs 较第一,三代…
Efficacy and safety of gefitinib as thirdline treatment in NSCLC patients with activating EGFR …
Efficacy and safety of gefitinib as thirdline treatment in NSCLC patients with activating EGFR …
[HTML][HTML] 表皮生长因子酪氨酸激酶抑制剂一线治疗突变阳性晚期非小细胞肺癌的临床疗效预测因素分析
陈闽江， 徐燕， 赵静， 钟巍， 王孟昭 - Chinese Journal of Lung …, 2019 - ncbi.nlm.nih.gov
… some dramatic efficacy in advanced non-small-cell lung cancer (NSCLC) patients with
activating … of clinical prognostic factors with EGFR-TKI efficacy in advanced NSCLC patients. …
activating … of clinical prognostic factors with EGFR-TKI efficacy in advanced NSCLC patients. …
[PDF][PDF] 陀螺旋转式立体定向放射治疗联合NP 方案治疗局部晚期非小细胞肺癌的临床疗效观察
张志南， 韩凤山， 韩正凯， 鹿双岭， 刘玉梅 - 2012 - biomed.cnjournals.com
… clinical curative effect of the observation and adverse reaction. … for patients with locally
advanced NSCLC compared … Safety and efficacy of pemetrexed in maintenance therapy of non-…
advanced NSCLC compared … Safety and efficacy of pemetrexed in maintenance therapy of non-…
晚期非小细胞肺癌EGFR 蛋白磷酸化, 基因突变与EGFR-TKI 疗效相关性的研究
王芬， 王洁， 白桦， 王书航， 王树滨， 申东兰 - 中国癌症杂志, 2014 - china-oncology.com
… ), represented by gefitinib and erlotinib, have exhibited … appeared in patients with pTyr1068
positive expression compared to … Akt phosphorylation and gefitinib efficacy in patients with …
positive expression compared to … Akt phosphorylation and gefitinib efficacy in patients with …
膀胱肿瘤靶向治疗现状及研究进展
殷小涛， 高江平 - 解放军医学院学报, 2017 - xuebao.301hospital.com.cn
… limits such as low efficacy, severe adverse effects and intolerance for some patients.
Recently, … :a comparison with p53 nuclear accumulation[J]. J Clin Oncol,2002,20(6):1544-1550. …
Recently, … :a comparison with p53 nuclear accumulation[J]. J Clin Oncol,2002,20(6):1544-1550. …
[PDF][PDF] 胰岛素样生长因子2 mRNA 结合蛋白2 (IGF2BP2) 在肺癌发生发展中的作用研究
刘鸿鸣 - 2017 - core.ac.uk
… of the lung: similarities and differences concerning the role of … sensitivity of tumors to
gefitinib and erlotinib. Proc. Natl Acad. … Efficacy of gefitinib, an inhibitor of the epidermal growth …
gefitinib and erlotinib. Proc. Natl Acad. … Efficacy of gefitinib, an inhibitor of the epidermal growth …